Track topics on Twitter Track topics that are important to you
The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms similar to HTLV infection.
Post-market, multi-center, study to support a diagnostic sample labeling claim. The Diagnostic Study will assess the performance of the HTLV Blot 2.4 with samples representative of clinical diagnostic samples (HTLV infected and conditions with symptoms similar to that HTLV). This study will use commercially available repository samples from qualified vendors. For neurological specimens not readily available in repository laboratories, prospection collection will be performed to meet the specimen enrollment goals.
MP Diagnostics HTLV Blot 2.4
Not yet recruiting
MP Biomedicals, LLC
Published on BioPortfolio: 2017-07-24T12:11:38-0400
The purpose of this study is to assess the validity and reproducibility of the MP Diagnostics HTLV Blot 2.4 in blood specimens testing repeat reactive (RR) on the first FDA licensed screen...
RATIONALE: Collecting information about HTLV-1 carriers and HTLV-1 associated illnesses in blood donors in Jamaica may help doctors learn more about these diseases. PURPOSE: This clinical...
The objective of this study is to assess the efficacy and safety of KW-0761 after intravenous injections in subjects with HTLV-1 associated myelopathy (HAM) in Japan.
HTLV-1 Associated Myelopathy is a chronic disease of the spinal cord, caused by a virus called human T lymphotropic virus type 1（HTLV−1）. Natural Killer cells provide rapid responses...
The InnoLIA HTLV I/II Score is an in vitro diagnostic test for confirmation of antibodies to human T-cell lymphotropic virus (HTLV) type I and type II in human blood samples. It is intend...
Human T-lymphotropic virus type 1 (HTLV-1) has been recognized as a cause of adult T-cell leukemia/lymphoma, HTLV-1-associated myelopathy/tropical spastic paraparesis, and HTLV-1-associated uveitis. H...
Human T-lymphotropic virus type 1 (HTLV-1) carriers may develop severe systemic diseases, such as adult T cell leukaemia (ATL) or HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). T...
We describe the first two cases of HTLV-1 associated uveitis to be associated with HTLV-1c subtype infection.
Molecular and epidemiological studies of transmission routes and risk factors for infection by HTLV-1 are extremely important in order to implement control measures, especially because of the high pre...
Human T lymphotropic virus type 1 (HTLV-1) belongs to the deltaretrovirus family and has been linked to multiple diseases. However, the innate host defense against HTLV-1 is unclear. In this study, we...
Infections caused by the HTLV or BLV deltaretroviruses. They include human T-cell leukemia-lymphoma (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED).
Antibodies reactive with the HTLV-I ANTIGENS.
Antibodies reactive with the HTLV-II ANTIGENS.
Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1.
Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2.